Literature DB >> 3674466

Effects of isoflurane and halothane on coronary vascular resistance and collateral myocardial blood flow: their capacity to induce coronary steal.

B A Cason1, E D Verrier, M J London, D T Mangano, R F Hickey.   

Abstract

Some coronary vasodilators, paradoxically, may endanger patients with coronary artery disease by causing "coronary steal." To determine the capacity of isoflurane and halothane to cause coronary steal, the authors studied their effects on coronary vascular resistance (CVR), diastolic coronary artery pressure, and collateral myocardial blood flow. Using ameroid constrictors, chronic occlusions of the left anterior descending (LAD) coronary artery were created in ten dogs. Six to eight weeks after implantation, the dogs were anesthetized with fentanyl and pentobarbital, and a stenosis was created on the circumflex (Cx) coronary artery. Isoflurane and halothane were each administered in doses of 0.5 and 1.5 MAC. Diastolic aortic pressure was held constant. Using small catheters in the circumflex and LAD coronary arteries, the authors measured diastolic coronary artery pressures. Collateral myocardial blood flow was measured by the microsphere method. In this model, halothane and isoflurane minimally affect CVR. The maximum change in CVR, which was found during 1.5 MAC isoflurane, was -8% (not significant). Diastolic coronary pressures distal to the Cx stenosis (54.5 +/- 11.5 mmHg) and distal to the LAD occlusion (44.5 +/- 5.2 mmHg) did not change significantly with either isoflurane or halothane. Transmural collateral blood flow distal to the LAD occlusion (0.51 +/- 0.11 cc.g-1.min-1) was unaltered by either drug. There was no evidence of coronary steal. Epicardial ECG S-T segments showed no evidence of ischemia. The finding of minimal direct effects of halothane and isoflurane on CVR, diastolic coronary pressure, and collateral myocardial blood flow suggest that, under the conditions of this study, neither agent, when used as an adjuvant to high-dose narcotic anesthesia, is likely to cause myocardial ischemia by a coronary "steal" mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674466     DOI: 10.1097/00000542-198711000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  4 in total

1.  ST segment depression repeatedly induced by isoflurane inhalation.

Authors:  Naofumi Iwatsuki; Toshio Saishu
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

2.  Severe regional ischemia alters coronary flow reserve in the remote perfusion area.

Authors:  J C Wu; J J Yun; D P Dione; E N Heller; L I Deckelbaum; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

3.  Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs.

Authors:  J C Hartman; P S Pagel; L T Proctor; J P Kampine; W T Schmeling; D C Warltier
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

4.  Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan.

Authors:  Eloísa Rubio-Beltrán; Alejandro Labastida-Ramírez; Kristian A Haanes; Antoon van den Bogaerdt; Ad J J C Bogers; Eric Zanelli; Laurent Meeus; A H Jan Danser; Michael R Gralinski; Peter B Senese; Kirk W Johnson; Joseph Kovalchin; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Br J Pharmacol       Date:  2019-11-07       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.